APA (7th ed.) Citation

Gernert, M., Schmalzing, M., Labinsky, H., Zhi, Y., Strunz, P., Fröhlich, M., . . . Serfling, S. E. (2026). CXCR4-targeted PET/CT in early systemic sclerosis–associated interstitial lung disease: A prospective proof-of-concept study of in vivo inflammatory activity. European Journal of Nuclear Medicine & Molecular Imaging, 1. https://doi.org/10.1007/s00259-026-08000-3

Chicago Style (17th ed.) Citation

Gernert, Michael, et al. "CXCR4-targeted PET/CT in Early Systemic Sclerosis–associated Interstitial Lung Disease: A Prospective Proof-of-concept Study of in Vivo Inflammatory Activity." European Journal of Nuclear Medicine & Molecular Imaging 2026: 1. https://doi.org/10.1007/s00259-026-08000-3.

MLA (9th ed.) Citation

Gernert, Michael, et al. "CXCR4-targeted PET/CT in Early Systemic Sclerosis–associated Interstitial Lung Disease: A Prospective Proof-of-concept Study of in Vivo Inflammatory Activity." European Journal of Nuclear Medicine & Molecular Imaging, 2026, p. 1, https://doi.org/10.1007/s00259-026-08000-3.